Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer’s disease: a systematic review
出版年份 2021 全文链接
标题
Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer’s disease: a systematic review
作者
关键词
Amyloid, Therapy, Alzheimer’s, MCI, Clinical trials, Immunotherapy, Hyperexcitability
出版物
AGEING RESEARCH REVIEWS
Volume 72, Issue -, Pages 101496
出版商
Elsevier BV
发表日期
2021-10-22
DOI
10.1016/j.arr.2021.101496
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Diagnosis and Management of Seizures in Neurodegenerative Diseases
- (2021) G. Adan et al. Current Treatment Options in Neurology
- Therapeutic potential of targeting G protein-gated inwardly rectifying potassium (GIRK) channels in the central nervous system
- (2021) Danko Jeremic et al. PHARMACOLOGY & THERAPEUTICS
- The Aβ(1–38) peptide is a negative regulator of the Aβ(1–42) peptide implicated in Alzheimer disease progression
- (2021) Maa O. Quartey et al. Scientific Reports
- Plasma contact factors as novel biomarkers for diagnosing Alzheimer’s disease
- (2021) Jung Eun Park et al. Biomarker Research
- Small-Molecule Targeted Aβ42 Aggregate Degradation: Negatively Charged Small Molecules Are More Promising than the Neutral Ones
- (2021) Jinfei Mei et al. ACS Chemical Neuroscience
- Therapy for Alzheimer’s disease: Missing Targets and Functional Markers?
- (2021) Milan Stoiljkovic et al. AGEING RESEARCH REVIEWS
- Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification
- (2021) Nicholas J. Izzo et al. Alzheimers & Dementia
- Apoptotic neurons and amyloid-beta clearance by phagocytosis in Alzheimer's disease: Pathological mechanisms and therapeutic outlooks
- (2021) Amir Tajbakhsh et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Donanemab in Early Alzheimer’s Disease
- (2021) Mark A. Mintun et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resting state EEG biomarkers of cognitive decline associated with Alzheimer’s disease and mild cognitive impairment
- (2021) Amir H. Meghdadi et al. PLoS One
- APOE and Alzheimer’s Disease: From Lipid Transport to Physiopathology and Therapeutics
- (2021) Mohammed Amir Husain et al. Frontiers in Neuroscience
- Amyloid-beta mediates homeostatic synaptic plasticity
- (2021) Christos Galanis et al. JOURNAL OF NEUROSCIENCE
- A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
- (2021) Chad J. Swanson et al. Alzheimers Research & Therapy
- Aducanumab produced a clinically meaningful benefit in association with amyloid lowering
- (2021) Jeffrey Cummings et al. Alzheimers Research & Therapy
- Predicting Dementia With Prefrontal Electroencephalography and Event-Related Potential
- (2021) Dieu Ni Thi Doan et al. Frontiers in Aging Neuroscience
- Neuronal excitation/inhibition imbalance: core element of a translational perspective on Alzheimer pathophysiology
- (2021) Fernando Maestú et al. AGEING RESEARCH REVIEWS
- G-Protein-Gated Inwardly Rectifying Potassium (Kir3/GIRK) Channels Govern Synaptic Plasticity That Supports Hippocampal-Dependent Cognitive Functions in Male Mice
- (2021) Souhail Djebari et al. JOURNAL OF NEUROSCIENCE
- The Amyloid-β Pathway in Alzheimer’s Disease
- (2021) Harald Hampel et al. MOLECULAR PSYCHIATRY
- Sensorineural hearing loss may lead to dementia-related pathological changes in hippocampal neurons
- (2021) Yilin Shen et al. NEUROBIOLOGY OF DISEASE
- An Investigation of Levetiracetam in Alzheimer’s Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study
- (2021) Arjune Sen et al. Trials
- Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer’s disease
- (2021) William T. Hu et al. Nature Communications
- Aducanumab for Alzheimer’s disease?
- (2021) Sebastian Walsh et al. BMJ-British Medical Journal
- Cholesterol and Alzheimer’s Disease; From Risk Genes to Pathological Effects
- (2021) Femke M. Feringa et al. Frontiers in Aging Neuroscience
- Role of Neuron and Glia in Alzheimer’s Disease and Associated Vascular Dysfunction
- (2021) Sanghamitra Bandyopadhyay Frontiers in Aging Neuroscience
- APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer’s disease and age-matched non-demented brains
- (2021) Joseph O. Ojo et al. Molecular Brain
- The Accelerated Approval of Aducanumab for Treatment of Patients With Alzheimer Disease
- (2021) Robert Steinbrook JAMA Internal Medicine
- Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity
- (2021) Keith Vossel et al. JAMA Neurology
- The multiplex model of the genetics of Alzheimer’s disease
- (2020) Rebecca Sims et al. NATURE NEUROSCIENCE
- APOE alters glucose flux through central carbon pathways in astrocytes
- (2020) Holden C. Williams et al. NEUROBIOLOGY OF DISEASE
- Associations between brain inflammatory profiles and human neuropathology are altered based on apolipoprotein E ε4 genotype
- (2020) Jacob S. Friedberg et al. Scientific Reports
- Pharmacokinetics and pharmacodynamic effect of crenezumab on plasma and cerebrospinal fluid beta-amyloid in patients with mild-to-moderate Alzheimer’s disease
- (2020) Kenta Yoshida et al. Alzheimers Research & Therapy
- Enhancing α-secretase Processing for Alzheimer’s Disease—A View on SFRP1
- (2020) Bor Luen Tang Brain Sciences
- Retinal Biomarkers of Alzheimer’s Disease
- (2020) Cecilia S. Lee et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Benefits and Harms of Prescription Drugs and Supplements for Treatment of Clinical Alzheimer-Type Dementia
- (2020) Howard A. Fink et al. ANNALS OF INTERNAL MEDICINE
- Is psoriasis associated with dementia or cognitive impairment? A Critically Appraised Topic
- (2020) H. Yen et al. BRITISH JOURNAL OF DERMATOLOGY
- A mechanistic hypothesis for the impairment of synaptic plasticity by soluble Ab oligomers from Alzheimer brain
- (2020) Shaomin Li et al. JOURNAL OF NEUROCHEMISTRY
- Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances
- (2020) Wenzhang Wang et al. Molecular Neurodegeneration
- d-Pinitol: a cyclitol with versatile biological and pharmacological activities
- (2020) Marina Sánchez-Hidalgo et al. PHYTOCHEMISTRY REVIEWS
- Hebbian and Homeostatic Synaptic Plasticity—Do Alterations of One Reflect Enhancement of the Other?
- (2020) Christos Galanis et al. Frontiers in Cellular Neuroscience
- Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer’s disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study
- (2020) Gerald Novak et al. Alzheimers Research & Therapy
- Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals
- (2020) Reisa A. Sperling et al. JAMA Neurology
- Pharmacotherapy of Alzheimer’s Disease: Seeking Clarity in a Time of Uncertainty
- (2020) Nurul Husna Ibrahim et al. Frontiers in Pharmacology
- The Important Interface Between Apolipoprotein E and Neuroinflammation in Alzheimer’s Disease
- (2020) Courtney M. Kloske et al. Frontiers in Immunology
- On the impact of age, gender and educational level on cognitive function in Alzheimer’s disease: A quantitative approach
- (2020) Azra Delpak et al. ARCHIVES OF GERONTOLOGY AND GERIATRICS
- Alzheimer’s Disease in Down Syndrome: Progress in the Design and Conduct of Drug Prevention Trials
- (2020) Michael S. Rafii CNS DRUGS
- Deciphering Alzheimer’s disease: predicting new therapeutic strategies via improved understanding of biology and pathogenesis
- (2020) Rita Khoury et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The ApoE locus and COVID-19: are we going where we have been?
- (2020) Caleb E Finch et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Characterization and preclinical evaluation of the cGMP grade DNA based vaccine, AV-1959D to enter the first-in-human clinical trials
- (2020) Irina Petrushina et al. NEUROBIOLOGY OF DISEASE
- Altered mitochondrial dynamics and function in APOE4-expressing astrocytes
- (2020) Eran Schmukler et al. Cell Death & Disease
- Aducanumab, gantenerumab, BAN2401, and ALZ-801—the first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval
- (2020) Martin Tolar et al. Alzheimers Research & Therapy
- Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia
- (2020) Suzanne Craft et al. JAMA Neurology
- Targeting Amyloidogenic Processing of APP in Alzheimer’s Disease
- (2020) Jing Zhao et al. Frontiers in Molecular Neuroscience
- Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease
- (2020) Alette M. Wessels et al. Alzheimers & Dementia
- Anticoagulants for Treatment of Alzheimer’s Disease
- (2020) Klaus Grossmann JOURNAL OF ALZHEIMERS DISEASE
- Genome-wide interaction analysis of pathological hallmarks in Alzheimer's disease
- (2020) Hui Wang et al. NEUROBIOLOGY OF AGING
- A phase II randomized trial of sodium oligomannate in Alzheimer’s dementia
- (2020) Tao Wang et al. Alzheimers Research & Therapy
- Late-onset vs nonmendelian early-onset Alzheimer disease
- (2020) Christiane Reitz et al. Neurology-Genetics
- BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer’s disease brain
- (2020) Cyrille Sur et al. BRAIN
- Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer’s Disease
- (2020) Sofia Toniolo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Retinal Optical Coherence Tomography Metrics Are Unchanged in Verubecestat Alzheimer’s Disease Clinical Trial but Correlate with Baseline Regional Brain Atrophy
- (2020) Robert C. Sergott et al. JOURNAL OF ALZHEIMERS DISEASE
- Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic
- (2020) Valero Sergi et al. Scientific Reports
- A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
- (2019) Francesco Panza et al. Nature Reviews Neurology
- Executive Functions in Alzheimer Disease: A Systematic Review
- (2019) Angela Guarino et al. Frontiers in Aging Neuroscience
- APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1
- (2019) Masaya Tachibana et al. JOURNAL OF CLINICAL INVESTIGATION
- Air Pollution and Dementia: A Systematic Review
- (2019) Ruth Peters et al. JOURNAL OF ALZHEIMERS DISEASE
- Neuronal apolipoprotein E4 increases cell death and phosphorylated tau release in alzheimer disease
- (2019) Anil R. Wadhwani et al. ANNALS OF NEUROLOGY
- Genetic origin of a large family with a novel PSEN1 mutation (Ile416Thr)
- (2019) Laura Ramirez Aguilar et al. Alzheimers & Dementia
- The Role of ApoE in HCV Infection and Comorbidity
- (2019) Yue Gong et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Natural Compounds for Alzheimer’s Disease Therapy: A Systematic Review of Preclinical and Clinical Studies
- (2019) Stephanie Andrade et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Alzheimer disease and aducanumab: adjusting our approach
- (2019) Dennis J. Selkoe Nature Reviews Neurology
- Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer’s Disease
- (2019) David Henley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease
- (2019) Michael F. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Delta-secretase-cleaved Tau antagonizes TrkB neurotrophic signalings, mediating Alzheimer’s disease pathologies
- (2019) Jie Xiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Substrate recognition and processing by γ-secretase
- (2019) Michael S. Wolfe BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Plasma kallikrein‐kinin system contributes to peripheral inflammation in temporal lobe epilepsy
- (2019) Priscila S.R. Simões et al. JOURNAL OF NEUROCHEMISTRY
- Advancements in nanotherapeutics for Alzheimer’s disease: current perspectives
- (2019) Seetha Harilal et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease
- (2019) Ramsey Najm et al. Molecular Neurodegeneration
- Deficiency in BDNF/TrkB Neurotrophic Activity Stimulates δ-Secretase by Upregulating C/EBPβ in Alzheimer’s Disease
- (2019) Zhi-Hao Wang et al. Cell Reports
- Modifiable Risk Factors for Alzheimer’s Disease
- (2019) George A. Edwards III et al. Frontiers in Aging Neuroscience
- Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease
- (2019) Christopher H. van Dyck et al. JAMA Neurology
- Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels: An Emerging Role in Neurodegenerative Diseases
- (2019) Xiaoli Chang et al. Frontiers in Molecular Neuroscience
- The microbiome: A target for Alzheimer disease?
- (2019) Dong-oh Seo et al. CELL RESEARCH
- Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression
- (2019) Xinyi Wang et al. CELL RESEARCH
- Tumor Necrosis Factor-α-Mediated Metaplastic Inhibition of LTP is Constitutively Engaged in an Alzheimer's Disease Model
- (2019) Anurag Singh et al. JOURNAL OF NEUROSCIENCE
- Early network dysfunction in Alzheimer's disease
- (2019) Dennis J. Selkoe SCIENCE
- A vicious cycle of β amyloid–dependent neuronal hyperactivation
- (2019) Benedikt Zott et al. SCIENCE
- Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer’s disease
- (2019) Michael F. Egan et al. Alzheimers Research & Therapy
- Rationale for the development of an Alzheimer’s disease vaccine
- (2019) Ping Kwan et al. Human Vaccines & Immunotherapeutics
- Secreted Amyloid Precursor Protein-Alpha Promotes Arc Protein Synthesis in Hippocampal Neurons
- (2019) Rhys W. Livingstone et al. Frontiers in Molecular Neuroscience
- The Age-Related Central Auditory Processing Disorder: Silent Impairment of the Cognitive Ear
- (2019) Rodolfo Sardone et al. Frontiers in Neuroscience
- Investigational BACE inhibitors for the treatment of Alzheimer’s disease
- (2019) Bruno P. Imbimbo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Current and Emerging Pharmacological Targets for the Treatment of Alzheimer’s Disease
- (2019) Ahmed Morsy et al. JOURNAL OF ALZHEIMERS DISEASE
- Developing Effective Alzheimer’s Disease Therapies: Clinical Experience and Future Directions
- (2019) David R. Elmaleh et al. JOURNAL OF ALZHEIMERS DISEASE
- Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease
- (2019) Alette M. Wessels et al. JAMA Neurology
- Apolipoprotein E regulates mitochondrial function through the PGC-1α-sirtuin 3 pathway
- (2019) Junxiang Yin et al. Aging-US
- A Phase I Study to Assess the Effect of Speed of Injection on Pain, Tolerability, and Pharmacokinetics After High-volume Subcutaneous Administration of Gantenerumab in Healthy Volunteers
- (2019) Agnès Portron et al. CLINICAL THERAPEUTICS
- Hippocampal long‐term synaptic depression and memory deficits induced in early amyloidopathy are prevented by enhancing G‐protein‐gated inwardly rectifying potassium channel activity
- (2019) Irene Sánchez‐Rodríguez et al. JOURNAL OF NEUROCHEMISTRY
- A resurrection of aducanumab for Alzheimer's disease
- (2019) Lon Schneider LANCET NEUROLOGY
- The Exposome in Human Evolution: From Dust to Diesel
- (2019) Benjamin C. Trumble et al. QUARTERLY REVIEW OF BIOLOGY
- Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer’s disease: a PET substudy interim analysis
- (2019) Gregory Klein et al. Alzheimers Research & Therapy
- Perturbations of Ubiquitin-Proteasome-Mediated Proteolysis in Aging and Alzheimer’s Disease
- (2019) Ashok N. Hegde et al. Frontiers in Aging Neuroscience
- Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts
- (2018) Rachel F. Buckley et al. Alzheimers & Dementia
- What Happens with the Circuit in Alzheimer's Disease in Mice and Humans?
- (2018) Benedikt Zott et al. Annual Review of Neuroscience
- Anti-Amyloid-β Monoclonal Antibodies for Alzheimer’s Disease: Pitfalls and Promise
- (2018) Christopher H. van Dyck BIOLOGICAL PSYCHIATRY
- Amyloid fibrils induce dysfunction of hippocampal glutamatergic silent synapses
- (2018) Bihua Bie et al. HIPPOCAMPUS
- Amyloid-β Induces AMPA Receptor Ubiquitination and Degradation in Primary Neurons and Human Brains of Alzheimer’s Disease
- (2018) Yanmin Zhang et al. JOURNAL OF ALZHEIMERS DISEASE
- Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model
- (2018) Dario Carradori et al. Nanomedicine-Nanotechnology Biology and Medicine
- Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector
- (2018) Chengzhong Wang et al. NATURE MEDICINE
- Imbalance between firing homeostasis and synaptic plasticity drives early-phase Alzheimer’s disease
- (2018) Boaz Styr et al. NATURE NEUROSCIENCE
- Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics
- (2018) Mark A. Petersen et al. NATURE REVIEWS NEUROSCIENCE
- Cortical β-amyloid burden, gray matter, and memory in adults at varying APOE ε4 risk for Alzheimer's disease
- (2018) Adam P. Mecca et al. NEUROBIOLOGY OF AGING
- Targeting demyelination via α-secretases promoting sAPPα release to enhance remyelination in central nervous system
- (2018) Gemma Llufriu-Dabén et al. NEUROBIOLOGY OF DISEASE
- Una revisión de los avances en la terapéutica de la enfermedad de Alzheimer: estrategia frente a la proteína β-amiloide
- (2018) J. Folch et al. NEUROLOGIA
- Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease
- (2018) Michael F. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
- (2018) Lawrence S. Honig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synaptic plasticity modulation by circulating peptides and metaplasticity: Involvement in Alzheimer’s disease
- (2018) Stéphane Peineau et al. PHARMACOLOGICAL RESEARCH
- Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH
- (2018) Hari Prasad et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Microbes and Alzheimer’s Disease: New Findings Call for a Paradigm Change
- (2018) Jürgen G. Haas et al. TRENDS IN NEUROSCIENCES
- C/EBPβ regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer’s disease
- (2018) Zhi-Hao Wang et al. Nature Communications
- Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial
- (2018) Ana-María Lacosta et al. Alzheimers Research & Therapy
- NSAID Exposure and Risk of Alzheimer's Disease: An Updated Meta-Analysis From Cohort Studies
- (2018) Caixia Zhang et al. Frontiers in Aging Neuroscience
- Theta-Gamma Coupling and Working Memory in Alzheimer’s Dementia and Mild Cognitive Impairment
- (2018) Michelle S. Goodman et al. Frontiers in Aging Neuroscience
- APOE and Alzheimer’s Disease: Neuroimaging of Metabolic and Cerebrovascular Dysfunction
- (2018) Jason A. Brandon et al. Frontiers in Aging Neuroscience
- Understanding the Role of Adenosine A2AR Heteroreceptor Complexes in Neurodegeneration and Neuroinflammation
- (2018) Dasiel O. Borroto-Escuela et al. Frontiers in Neuroscience
- Impact of Aging on the Auditory System and Related Cognitive Functions: A Narrative Review
- (2018) Dona M. P. Jayakody et al. Frontiers in Neuroscience
- The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease
- (2018) Ulf Neumann et al. EMBO Molecular Medicine
- Epileptic Seizures in Alzheimer's Disease: Another Fine MESS?
- (2018) Andrew J. Larner et al. JOURNAL OF ALZHEIMERS DISEASE
- Blood Transcriptomic Biomarkers of Alzheimer's Disease Patients Treated with EHT 0202
- (2018) Laurent Désiré et al. JOURNAL OF ALZHEIMERS DISEASE
- Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau
- (2018) Silvia S. Kang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease
- (2018) Eric McDade et al. NEUROLOGY
- Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer’s disease: randomized, double-blind, placebo-controlled study
- (2018) Maarten Timmers et al. Alzheimers Research & Therapy
- Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's disease
- (2018) W. Robert Bell et al. Alzheimers & Dementia
- The Reelin Receptors Apolipoprotein E receptor 2 (ApoER2) and VLDL Receptor
- (2018) Paula Dlugosz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical Evaluation of Amyloid-Related Imaging Abnormalities in Bapineuzumab Phase III Studies
- (2018) H. Robert Brashear et al. JOURNAL OF ALZHEIMERS DISEASE
- A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer’s Disease
- (2018) Martin R. Farlow et al. JOURNAL OF ALZHEIMERS DISEASE
- Synaptotoxicity in Alzheimer's Disease Involved a Dysregulation of Actin Cytoskeleton Dynamics through Cofilin 1 Phosphorylation
- (2018) Travis Rush et al. JOURNAL OF NEUROSCIENCE
- Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer’s disease
- (2018) Xunde Xian et al. eLife
- Sensorial frailty: age-related hearing loss and the risk of cognitive impairment and dementia in later life
- (2018) Francesco Panza et al. Therapeutic Advances in Chronic Disease
- APOEε4 impacts up-regulation of brain-derived neurotrophic factor after a six-month stretch and aerobic exercise intervention in mild cognitively impaired elderly African Americans: A pilot study
- (2017) Joanne S. Allard et al. EXPERIMENTAL GERONTOLOGY
- The potential of solanezumab and gantenerumab to prevent Alzheimer’s disease in people with inherited mutations that cause its early onset
- (2017) Francesco Panza et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Bryostatin Effects on Cognitive Function and PKCɛ in Alzheimer’s Disease Phase IIa and Expanded Access Trials
- (2017) Thomas J. Nelson et al. JOURNAL OF ALZHEIMERS DISEASE
- Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer’s Disease Patients
- (2017) Nzeera Ketter et al. JOURNAL OF ALZHEIMERS DISEASE
- Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer’s Disease: The Role of APP
- (2017) Eric Doran et al. JOURNAL OF ALZHEIMERS DISEASE
- Optical Coherence Tomography Reveals Retinal Neuroaxonal Thinning in Frontotemporal Dementia as in Alzheimer’s Disease
- (2017) Laura Ferrari et al. JOURNAL OF ALZHEIMERS DISEASE
- Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer’s disease Neurons
- (2017) Ravi Rajmohan et al. JOURNAL OF ALZHEIMERS DISEASE
- The role of APOE on lipid homeostasis and inflammation in normal brains
- (2017) G. William Rebeck JOURNAL OF LIPID RESEARCH
- Epileptic activity in Alzheimer's disease: causes and clinical relevance
- (2017) Keith A Vossel et al. LANCET NEUROLOGY
- ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy
- (2017) Yang Shi et al. NATURE
- Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer's disease
- (2017) Alice D Lam et al. NATURE MEDICINE
- A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain
- (2017) Jun Wang et al. Nature Reviews Neurology
- A phase 3 trial of IV immunoglobulin for Alzheimer disease
- (2017) Norman R. Relkin et al. NEUROLOGY
- Apolipoprotein E4 Impairs Neuronal Insulin Signaling by Trapping Insulin Receptor in the Endosomes
- (2017) Na Zhao et al. NEURON
- ApoE4 Accelerates Early Seeding of Amyloid Pathology
- (2017) Chia-Chen Liu et al. NEURON
- The past, present, and future of disease-modifying therapies for Alzheimer’s disease
- (2017) Kazushi SUZUKI et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Metaplasticity mechanisms restore plasticity and associativity in an animal model of Alzheimer’s disease
- (2017) Qin Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Brief Overview of Tauopathy: Causes, Consequences, and Therapeutic Strategies
- (2017) Miranda E. Orr et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Amyloid β-peptides 1–40 and 1–42 form oligomers with mixed β-sheets
- (2017) Maurizio Baldassarre et al. Chemical Science
- Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer’s disease-like pathology
- (2017) Tal Nuriel et al. Nature Communications
- Apolipoprotein E4 and Insulin Resistance Interact to Impair Cognition and Alter the Epigenome and Metabolome
- (2017) Lance A. Johnson et al. Scientific Reports
- A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
- (2017) Susanne Ostrowitzki et al. Alzheimers Research & Therapy
- Enhanced Gamma Activity and Cross-Frequency Interaction of Resting-State Electroencephalographic Oscillations in Patients with Alzheimer’s Disease
- (2017) Jing Wang et al. Frontiers in Aging Neuroscience
- Clearance of beta-amyloid is facilitated by apolipoprotein E and circulating high-density lipoproteins in bioengineered human vessels
- (2017) Jerome Robert et al. eLife
- Particulate air pollutants, APOE alleles and their contributions to cognitive impairment in older women and to amyloidogenesis in experimental models
- (2017) M Cacciottolo et al. Translational Psychiatry
- Optical Coherence Tomography in Alzheimer’s Disease and Other Neurodegenerative Diseases
- (2017) Jonah Doustar et al. Frontiers in Neurology
- Locus coeruleus cellular and molecular pathology during the progression of Alzheimer’s disease
- (2017) Sarah C. Kelly et al. Acta Neuropathologica Communications
- BDNF Genetic Variations Increase the Risk of Alzheimer's Disease-Related Depression
- (2017) Barbara Borroni et al. JOURNAL OF ALZHEIMERS DISEASE
- Alzheimer's Disease and the Amyloid-β Peptide
- (2017) M. Paul Murphy et al. JOURNAL OF ALZHEIMERS DISEASE
- Activation of G-protein-gated inwardly rectifying potassium (Kir3/GirK) channels rescues hippocampal functions in a mouse model of early amyloid-β pathology
- (2017) Irene Sánchez-Rodríguez et al. Scientific Reports
- The role of APOE in cerebrovascular dysfunction
- (2016) Leon M. Tai et al. ACTA NEUROPATHOLOGICA
- Epileptic Seizures in Alzheimer Disease
- (2016) András Horváth et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- SAFETY, PHARMACOKINETICS (PK), AND FLORBETAPIR F-18 POSITRON EMISSION TOMOGRAPHY (PET) AFTER MULTIPLE DOSE ADMINISTRATION OF LY3002813, A β-AMYLOID PLAQUE-SPECIFIC ANTIBODY, IN ALZHEIMER’S DISEASE (AD)
- (2016) Michael C. Irizarry et al. Alzheimers & Dementia
- CLINICAL TRIAL DESIGN OF CREAD: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP PHASE 3 STUDY TO EVALUATE CRENEZUMAB TREATMENT IN PATIENTS WITH PRODROMAL-TO-MILD ALZHEIMER’S DISEASE
- (2016) Thomas Blaettler et al. Alzheimers & Dementia
- Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels
- (2016) Ganesh M. Babulal et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- APOE4 Induces Site-Specific Tau Phosphorylation Through Calpain-CDK5 Signaling Pathway in EFAD-Tg Mice
- (2016) Meng Zhou et al. Current Alzheimer Research
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- Targeting neuroinflammation in Alzheimer’s disease: evidence for NSAIDs and novel therapeutics
- (2016) William James Deardorff et al. Expert Review of Neurotherapeutics
- AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer’s Disease
- (2016) Gvido Cebers et al. JOURNAL OF ALZHEIMERS DISEASE
- Two Phase 2 Multiple Ascending–Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer’s Disease
- (2016) Florence Pasquier et al. JOURNAL OF ALZHEIMERS DISEASE
- Gamma Secretase Modulators: New Alzheimer’s Drugs on the Horizon?
- (2016) Matthew G. Bursavich et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mechanisms of homeostatic plasticity in the excitatory synapse
- (2016) Dominique Fernandes et al. JOURNAL OF NEUROCHEMISTRY
- Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial
- (2016) Rafael de la Torre et al. LANCET NEUROLOGY
- Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer’s disease
- (2016) T A Pascoal et al. MOLECULAR PSYCHIATRY
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Network abnormalities and interneuron dysfunction in Alzheimer disease
- (2016) Jorge J. Palop et al. NATURE REVIEWS NEUROSCIENCE
- Impairments of neural circuit function in Alzheimer's disease
- (2016) Marc Aurel Busche et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer’s disease
- (2016) Johnny Habchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The BACE1 inhibitor verubecestat (MK-8931) reduces CNS -amyloid in animal models and in Alzheimers disease patients
- (2016) M. E. Kennedy et al. Science Translational Medicine
- Canonical and Non-canonical Reelin Signaling
- (2016) Hans H. Bock et al. Frontiers in Cellular Neuroscience
- Impaired theta-gamma coupling in APP-deficient mice
- (2016) Xiaomin Zhang et al. Scientific Reports
- Long-term safety and tolerability of bapineuzumab in patients with Alzheimer’s disease in two phase 3 extension studies
- (2016) Adrian Ivanoiu et al. Alzheimers Research & Therapy
- Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials
- (2016) Rik Vandenberghe et al. Alzheimers Research & Therapy
- Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody
- (2016) Veronika Logovinsky et al. Alzheimers Research & Therapy
- Targeting neuroinflammation in Alzheimer’s disease: evidence for NSAIDs and novel therapeutics
- (2016) William James Deardorff et al. Expert Review of Neurotherapeutics
- The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
- (2016) Urmi Sengupta et al. EBioMedicine
- Amyloid β oligomers in Alzheimer’s disease pathogenesis, treatment, and diagnosis
- (2015) Kirsten L. Viola et al. ACTA NEUROPATHOLOGICA
- Vanutide Cridificar and the QS-21 Adjuvant in Japanese Subjects with Mild to Moderate Alzheimer’ s Disease: Results from Two Phase 2 Studies
- (2015) Heii Arai et al. Current Alzheimer Research
- IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia
- (2015) Shawn Kile et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Rescue of long-range circuit dysfunction in Alzheimer's disease models
- (2015) Marc Aurel Busche et al. NATURE NEUROSCIENCE
- A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome
- (2015) Frances K. Wiseman et al. NATURE REVIEWS NEUROSCIENCE
- The storm before the quiet: neuronal hyperactivity and Aβ in the presymptomatic stages of Alzheimer's disease
- (2015) Anita Stargardt et al. NEUROBIOLOGY OF AGING
- Amyloid-β11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials
- (2015) Enchi Liu et al. NEUROLOGY
- Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders
- (2015) Elvira Valera et al. Neurotherapeutics
- Amyloid-β(25-35) Modulates the Expression of GirK and KCNQ Channel Genes in the Hippocampus
- (2015) Jennifer Mayordomo-Cava et al. PLoS One
- The alpha secretase ADAM10: A metalloprotease with multiple functions in the brain
- (2015) Paul Saftig et al. PROGRESS IN NEUROBIOLOGY
- Quality of Life and Utility Measurement in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer’s Disease: Determinants and Level of Changes Observed
- (2015) Loretto Lacey et al. VALUE IN HEALTH
- Peripheral and central effects of γ-secretase inhibition by semagacestat in Alzheimer’s disease
- (2015) Rachelle S Doody et al. Alzheimers Research & Therapy
- Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer’s disease
- (2015) Martin R Farlow et al. Alzheimers Research & Therapy
- The roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease
- (2015) Naoyuki Sato et al. Frontiers in Aging Neuroscience
- Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance
- (2015) Arnold Bakker et al. NeuroImage-Clinical
- Optical Coherence Tomography in Alzheimer’s Disease: A Meta-Analysis
- (2015) Gianluca Coppola et al. PLoS One
- Primary age-related tauopathy (PART): a common pathology associated with human aging
- (2014) John F. Crary et al. ACTA NEUROPATHOLOGICA
- The multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes
- (2014) Hoang S. Nhan et al. ACTA NEUROPATHOLOGICA
- Effect of TTP488 in patients with mild to moderate Alzheimer’s disease
- (2014) Aaron H Burstein et al. BMC Neurology
- Reelin Signaling Specifies the Molecular Identity of the Pyramidal Neuron Distal Dendritic Compartment
- (2014) Justine V. Kupferman et al. CELL
- Anti-amyloidogenic effects of ID1201, the ethanolic extract of the fruits of Melia toosendan, through activation of the phosphatidylinositol 3-kinase/Akt pathway
- (2014) Hanbyeol Park et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Synapto-depressive effects of amyloid beta require PICK1
- (2014) Stephanie Alfonso et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Efficacy and safety studies of gantenerumab in patients with Alzheimer’s disease
- (2014) Francesco Panza et al. Expert Review of Neurotherapeutics
- Alzheimer Presenilin-1 Mutations Dramatically Reduce Trimming of Long Amyloid β-Peptides (Aβ) by γ-Secretase to Increase 42-to-40-Residue Aβ
- (2014) Marty A. Fernandez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Confirmatory population pharmacokinetic analysis for bapineuzumab phase 3 studies in patients with mild to moderate Alzheimer's disease
- (2014) Chuanpu Hu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The N-terminal Region of Amyloid β Controls the Aggregation Rate and Fibril Stability at Low pH Through a Gain of Function Mechanism
- (2014) Kristoffer Brännström et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Apolipoprotein E in Synaptic Plasticity and Alzheimer’s Disease: Potential Cellular and Molecular Mechanisms
- (2014) Jaekwang Kim et al. MOLECULES AND CELLS
- Apolipoprotein E–low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner
- (2014) Lance A. Johnson et al. NEUROBIOLOGY OF DISEASE
- Increased CSF APPs- levels in patients with Alzheimer disease treated with acitretin
- (2014) K. Endres et al. NEUROLOGY
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- The γ-secretase complex: from structure to function
- (2014) Xian Zhang et al. Frontiers in Cellular Neuroscience
- GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer’s disease
- (2014) Mauricio O. Nava-Mesa et al. Frontiers in Cellular Neuroscience
- Fyn kinase inhibition as a novel therapy for Alzheimer’s disease
- (2014) Haakon B Nygaard et al. Alzheimers Research & Therapy
- Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics
- (2014) William F Goure et al. Alzheimers Research & Therapy
- Amyloid-β and Tau
- (2014) George S. Bloom JAMA Neurology
- Safety and Pharmacology of Ponezumab (PF-04360365) After a Single 10-Minute Intravenous Infusion in Subjects With Mild to Moderate Alzheimer Disease
- (2013) Aaron H. Burstein et al. CLINICAL NEUROPHARMACOLOGY
- Safety and Pharmacology of a Single Intravenous Dose of Ponezumab in Subjects With Mild-to-Moderate Alzheimer Disease
- (2013) Jaren W. Landen et al. CLINICAL NEUROPHARMACOLOGY
- EEG theta/beta ratio as a potential biomarker for attentional control and resilience against deleterious effects of stress on attention
- (2013) Peter Putman et al. COGNITIVE AFFECTIVE & BEHAVIORAL NEUROSCIENCE
- CHF5074 Reduces Biomarkers of Neuroinflammation in Patients with Mild Cognitive Impairment: A 12-Week, Double-Blind, Placebo- Controlled Study
- (2013) Joel Ross et al. Current Alzheimer Research
- Safety and pharmacokinetics of PF-04360365 following a single-dose intravenous infusion in Japanese subjects with mild-to-moderate Alzheimerâs disease: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation study
- (2013) Izuru Miyoshi et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Endocytosis of synaptic ADAM10 in neuronal plasticity and Alzheimer’s disease
- (2013) Elena Marcello et al. JOURNAL OF CLINICAL INVESTIGATION
- Antibodies bound to Aβ oligomers potentiate the neurotoxicity of Aβ by activating microglia
- (2013) Ramune Morkuniene et al. JOURNAL OF NEUROCHEMISTRY
- Dab1 Is Required for Synaptic Plasticity and Associative Learning
- (2013) J. Trotter et al. JOURNAL OF NEUROSCIENCE
- Immunogenicity, Efficacy, Safety, and Mechanism of Action of Epitope Vaccine (Lu AF20513) for Alzheimer's Disease: Prelude to a Clinical Trial
- (2013) H. Davtyan et al. JOURNAL OF NEUROSCIENCE
- Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial
- (2013) Richard Dodel et al. LANCET NEUROLOGY
- Infectious burden and cognitive function: The Northern Manhattan Study
- (2013) M. Katan et al. NEUROLOGY
- Pulse pressure is associated with Alzheimer biomarkers in cognitively normal older adults
- (2013) D. A. Nation et al. NEUROLOGY
- A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- (2013) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- A induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss
- (2013) M. Talantova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ApoE influences amyloid- (A ) clearance despite minimal apoE/A association in physiological conditions
- (2013) P. B. Verghese et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Amyloid-β induces synaptic dysfunction through G protein-gated inwardly rectifying potassium channels in the fimbria-CA3 hippocampal synapse
- (2013) Mauricio O. Nava-Mesa et al. Frontiers in Cellular Neuroscience
- Seizures and Epileptiform Activity in the Early Stages of Alzheimer Disease
- (2013) Keith A. Vossel et al. JAMA Neurology
- Pharmacokinetics and Pharmacodynamics of CHF5074 After Short-term Administration in Healthy Subjects
- (2012) Bruno P. Imbimbo et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Amyloid-beta oligomerization in Alzheimer dementia versus high-pathology controls
- (2012) Thomas J. Esparza et al. ANNALS OF NEUROLOGY
- Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease
- (2012) Henrik Zetterberg ARCHIVES OF NEUROLOGY
- Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
- (2012) Vladimir Coric et al. ARCHIVES OF NEUROLOGY
- Deficiency in Mural Vascular Cells Coincides with Blood-Brain Barrier Disruption in Alzheimer's Disease
- (2012) Jesse D. Sengillo et al. BRAIN PATHOLOGY
- A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ-secretase inhibitor avagacestat
- (2012) Gary Tong et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Inhibitory Interneuron Deficit Links Altered Network Activity and Cognitive Dysfunction in Alzheimer Model
- (2012) Laure Verret et al. CELL
- Effects of Single Doses of Avagacestat (BMS-708163) on Cerebrospinal Fluid Aβ Levels in Healthy Young Men
- (2012) Gary Tong et al. CLINICAL DRUG INVESTIGATION
- A Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Avagacestat (BMS-708163) in Healthy Young and Elderly Subjects
- (2012) Randy Dockens et al. CLINICAL PHARMACOKINETICS
- Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study of the Oral γ-Secretase Inhibitor BMS-708163 (Avagacestat): Tolerability Profile, Pharmacokinetic Parameters, and Pharmacodynamic Markers
- (2012) Gary Tong et al. CLINICAL THERAPEUTICS
- Cognitive reserve in ageing and Alzheimer's disease
- (2012) Yaakov Stern LANCET NEUROLOGY
- Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study
- (2012) Bengt Winblad et al. LANCET NEUROLOGY
- Preclinical sporadic Alzheimer's disease: target for personalized diagnosis and preventive intervention
- (2012) Theodore B. VanItallie METABOLISM-CLINICAL AND EXPERIMENTAL
- Vaccination with a non-human random sequence amyloid oligomer mimic results in improved cognitive function and reduced plaque deposition and micro hemorrhage in Tg2576 mice
- (2012) Suhail Rasool et al. Molecular Neurodegeneration
- Apolipoprotein E Sets the Stage: Response to Injury Triggers Neuropathology
- (2012) Robert W. Mahley et al. NEURON
- Reduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive Impairment
- (2012) Arnold Bakker et al. NEURON
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Central Presbycusis
- (2012) George A. Gates OTOLARYNGOLOGY-HEAD AND NECK SURGERY
- Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model
- (2012) P. E. Sanchez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of AFFITOPE Alzheimer vaccines: Results of phase I studies with AD01 and AD02
- (2011) Markus Mandler et al. Alzheimers & Dementia
- Cholesterol Level and Statin Use in Alzheimer Disease
- (2011) Nina E. Shepardson ARCHIVES OF NEUROLOGY
- Cholesterol Level and Statin Use in Alzheimer Disease
- (2011) Nina E. Shepardson ARCHIVES OF NEUROLOGY
- Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
- (2011) Susanne Ostrowitzki ARCHIVES OF NEUROLOGY
- The Second-Generation Active A Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects
- (2011) C. Wiessner et al. JOURNAL OF NEUROSCIENCE
- PSD-95 and PSD-93 Play Critical But Distinct Roles in Synaptic Scaling Up and Down
- (2011) Q. Sun et al. JOURNAL OF NEUROSCIENCE
- Hippocampal Hyperactivation Associated with Cortical Thinning in Alzheimer's Disease Signature Regions in Non-Demented Elderly Adults
- (2011) D. Putcha et al. JOURNAL OF NEUROSCIENCE
- A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease
- (2011) S. Salloway et al. NEUROLOGY
- Soluble amyloid -protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
- (2011) M. Jin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long-Term Potentiation at CA3–CA1 Hippocampal Synapses with Special Emphasis on Aging, Disease, and Stress
- (2011) Ashok Kumar Frontiers in Aging Neuroscience
- Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Aβ42 immunisation in Alzheimer’s disease
- (2010) Delphine Boche et al. ACTA NEUROPATHOLOGICA
- A Single Ascending Dose Study of Bapineuzumab in Patients With Alzheimer Disease
- (2010) Ronald S. Black et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease
- (2010) Marwan N. Sabbagh et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Small moleculeβ-amyloid inhibitors that stabilize protofibrillar structuresin vitroimprove cognition and pathology in a mouse model of Alzheimer’s disease
- (2010) Cheryl A. Hawkes et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Review Article: Genetics of Alzheimer Disease
- (2010) Lynn M. Bekris et al. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
- The amyloid precursor protein intracellular domain (AICD) disrupts actin dynamics and mitochondrial bioenergetics
- (2010) Manus W. Ward et al. JOURNAL OF NEUROCHEMISTRY
- A -Mediated NMDA Receptor Endocytosis in Alzheimer's Disease Involves Ubiquitination of the Tyrosine Phosphatase STEP61
- (2010) P. Kurup et al. JOURNAL OF NEUROSCIENCE
- 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
- (2010) Juha O Rinne et al. LANCET NEUROLOGY
- Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
- (2010) Jorge J Palop et al. NATURE NEUROSCIENCE
- Fibrinogen and β-Amyloid Association Alters Thrombosis and Fibrinolysis: A Possible Contributing Factor to Alzheimer's Disease
- (2010) Marta Cortes-Canteli et al. NEURON
- Cross-frequency coupling supports multi-item working memory in the human hippocampus
- (2010) N. Axmacher et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling
- (2010) Y. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Decreased Clearance of CNS -Amyloid in Alzheimer's Disease
- (2010) K. G. Mawuenyega et al. SCIENCE
- Epilepsy and Cognitive Impairments in Alzheimer Disease
- (2009) Jorge J. Palop ARCHIVES OF NEUROLOGY
- Levetiracetam inhibits glutamate transmission through presynaptic P/Q-type calcium channels on the granule cells of the dentate gyrus
- (2009) Chun-Yao Lee et al. BRITISH JOURNAL OF PHARMACOLOGY
- Alternative Aβ Immunotherapy Approaches for Alzheimers Disease
- (2009) Terrence Town CNS & Neurological Disorders-Drug Targets
- Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders
- (2009) Bruno Vellas et al. Current Alzheimer Research
- Foramen ovale electrodes in the preoperative evaluation of temporal lobe epilepsy in children
- (2009) Daniel Nilsson et al. EPILEPSIA
- Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer DiseaseA Randomized Controlled Trial
- (2009) Robert C. Green JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Physical Activity, Diet, and Risk of Alzheimer Disease
- (2009) Nikolaos Scarmeas JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- β-Amyloid Impairs AMPA Receptor Trafficking and Function by Reducing Ca2+/Calmodulin-dependent Protein Kinase II Synaptic Distribution
- (2009) Zhenglin Gu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NMDA receptor-dependent signaling pathways that underlie amyloid β-protein disruption of LTP in the hippocampus
- (2009) Ghiam Yamin JOURNAL OF NEUROSCIENCE RESEARCH
- A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
- (2009) S. Salloway et al. NEUROLOGY
- Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without Dementia
- (2009) Reisa A. Sperling et al. NEURON
- Phase-dependent neuronal coding of objects in short-term memory
- (2009) Markus Siegel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Theta-gamma coupling increases during the learning of item-context associations
- (2009) A. B. L. Tort et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective induction of calcineurin activity and signaling by oligomeric amyloid beta
- (2008) Lindsay C. Reese et al. AGING CELL
- Effect of Physical Activity on Cognitive Function in Older Adults at Risk for Alzheimer Disease
- (2008) Nicola T. Lautenschlager et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- p75 Neurotrophin Receptor Mediates Neuronal Cell Death by Activating GIRK Channels through Phosphatidylinositol 4,5-Bisphosphate
- (2008) E. J. Coulson et al. JOURNAL OF NEUROSCIENCE
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial
- (2008) Gordon K Wilcock et al. LANCET NEUROLOGY
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
- Inhibition of LTP by beta-amyloid is prevented by activation of β2 adrenoceptors and stimulation of the cAMP/PKA signalling pathway
- (2008) Qin-wen Wang et al. NEUROBIOLOGY OF AGING
- 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease
- (2008) Norman R. Relkin et al. NEUROBIOLOGY OF AGING
- Overactivation of calcineurin induced by amyloid-beta and prion proteins
- (2008) Paula Agostinho et al. NEUROCHEMISTRY INTERNATIONAL
- Inhibition of LTP in vivo by beta-amyloid peptide in different conformational states
- (2007) Adrien W. Schmid et al. BRAIN RESEARCH
- Synaptic plasticity, memory and the hippocampus: a neural network approach to causality
- (2007) Guilherme Neves et al. NATURE REVIEWS NEUROSCIENCE
- Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: Insights from functional MRI studies
- (2007) Bradford C. Dickerson et al. NEUROPSYCHOLOGIA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now